Aethlon Medical, Inc.
AEMD
$4.21
-$0.23-5.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -17.62% | -10.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.62% | -10.56% | |||
| Operating Income | 17.62% | 10.56% | |||
| Income Before Tax | 15.60% | 71.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.60% | 71.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.60% | 71.83% | |||
| EBIT | 17.62% | 10.56% | |||
| EBITDA | 18.31% | 10.95% | |||
| EPS Basic | 55.91% | 75.34% | |||
| Normalized Basic EPS | 56.90% | 75.34% | |||
| EPS Diluted | 55.91% | 75.34% | |||
| Normalized Diluted EPS | 56.90% | 75.34% | |||
| Average Basic Shares Outstanding | 91.47% | 14.19% | |||
| Average Diluted Shares Outstanding | 91.47% | 14.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||